BBZA.DE
Price:
$30.7
Market Cap:
$1.56B
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Industry
Biotechnology
IPO Date
2020-06-29
Stock Exchange
XETRA
Ticker
BBZA.DE
According to BB Biotech AG’s latest financial reports and current stock price. The company's current PE Ratio is 12.53. This represents a change of 4.26% compared to the average of 0.29 of the last 4 quarters.
The mean historical PE Ratio of BB Biotech AG over the last ten years is 0.59. The current 12.53 PE Ratio has changed 211.97% with respect to the historical average. Over the past ten years (40 quarters), BBZA.DE's PE Ratio was at its highest in in the March 2018 quarter at 32.86. The PE Ratio was at its lowest in in the June 2023 quarter at -40.68.
Average
0.59
Median
0.60
Minimum
-11.34
Maximum
25.65
Discovering the peaks and valleys of BB Biotech AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 174.79%
Maximum Annual PE Ratio = 25.65
Minimum Annual Increase = -326.22%
Minimum Annual PE Ratio = -11.34
Year | PE Ratio | Change |
---|---|---|
2024 | 25.65 | -326.22% |
2023 | -11.34 | 33.62% |
2022 | -8.49 | -19.57% |
2021 | -10.55 | -277.56% |
2020 | 5.94 | 9.68% |
2019 | 5.42 | -176.02% |
2018 | -7.13 | -237.15% |
2017 | 5.20 | -236.87% |
2016 | -3.80 | -175.92% |
2015 | 5.00 | 174.79% |
The current PE Ratio of BB Biotech AG (BBZA.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.94
5-year avg
0.24
10-year avg
0.59
BB Biotech AG’s PE Ratio is greater than MorphoSys AG (-5.54), less than Qiagen N.V. (108.87), less than freenet AG (16.40), less than Bechtle AG (20.31), greater than United Internet AG (-79.84),
Company | PE Ratio | Market cap |
---|---|---|
-5.54 | $2.53B | |
108.87 | $8.16B | |
16.40 | $4.05B | |
20.31 | $4.99B | |
-79.84 | $3.80B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BB Biotech AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BB Biotech AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BB Biotech AG's PE Ratio?
How is the PE Ratio calculated for BB Biotech AG (BBZA.DE)?
What is the highest PE Ratio for BB Biotech AG (BBZA.DE)?
What is the 3-year average PE Ratio for BB Biotech AG (BBZA.DE)?
What is the 5-year average PE Ratio for BB Biotech AG (BBZA.DE)?
How does the current PE Ratio for BB Biotech AG (BBZA.DE) compare to its historical average?